138 related articles for article (PubMed ID: 3282706)
1. Potentiation of platinum analogue cytotoxicity by hyperthermia.
Xu MJ; Alberts DS
Cancer Chemother Pharmacol; 1988; 21(3):191-6. PubMed ID: 3282706
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo.
Kusumoto T; Holden SA; Ara G; Teicher BA
Int J Hyperthermia; 1995; 11(4):575-86. PubMed ID: 7594810
[TBL] [Abstract][Full Text] [Related]
3. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
Alberts DS; Fanta PT; Running KL; Adair LP; Garcia DJ; Liu-Stevens R; Salmon SE
Cancer Chemother Pharmacol; 1997; 39(6):493-7. PubMed ID: 9118460
[TBL] [Abstract][Full Text] [Related]
4. Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide.
Cohen JD; Robins HI; Schmitt CL
Cancer Lett; 1989 Mar; 44(3):205-10. PubMed ID: 2647285
[TBL] [Abstract][Full Text] [Related]
5. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
Perez RP; O'Dwyer PJ; Handel LM; Ozols RF; Hamilton TC
Int J Cancer; 1991 May; 48(2):265-9. PubMed ID: 2019469
[TBL] [Abstract][Full Text] [Related]
6. Heat enhances the cytotoxicity of cis-diamminedichloroplatinum(II) and its analogues cis-1,1-cyclobutane-dicarboxylato(2R)-2-methyl-1,4- butanediammineplatinum(II) and cis-diammine(glycolato)platinum in vitro.
Takahashi I; Maehara Y; Kusumoto H; Kohnoe S; Sugimachi K
Cancer Chemother Pharmacol; 1993; 33(1):31-5. PubMed ID: 8269586
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells.
Rietbroek RC; van de Vaart PJ; Haveman J; Blommaert FA; Geerdink A; Bakker PJ; Veenhof CH
J Cancer Res Clin Oncol; 1997; 123(1):6-12. PubMed ID: 8996534
[TBL] [Abstract][Full Text] [Related]
8. Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo.
Epelbaum R; Teicher BA; Holden SA; Ara G; Varshney A; Herman TS
Eur J Cancer; 1992; 28A(4-5):794-800. PubMed ID: 1524897
[TBL] [Abstract][Full Text] [Related]
9. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
Sharp SY; Mistry P; Valenti MR; Bryant AP; Kelland LR
Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990
[TBL] [Abstract][Full Text] [Related]
10. In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin.
Dodion P; Sanders C; Georges P; Kenis Y
Cancer Chemother Pharmacol; 1988; 22(1):80-2. PubMed ID: 3293841
[TBL] [Abstract][Full Text] [Related]
11. [Effects of hyperthermia combined platinum-based drugs on ovarian cancer cell lines SKOV3].
Xie D; Yin RT; Li KM; Xiao P; Tong LX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):606-11. PubMed ID: 25286685
[TBL] [Abstract][Full Text] [Related]
12. A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity.
Los G; Smals OA; van Vugt MJ; van der Vlist M; den Engelse L; McVie JG; Pinedo HM
Cancer Res; 1992 Mar; 52(5):1252-8. PubMed ID: 1737387
[TBL] [Abstract][Full Text] [Related]
13. In vitro interactions between platinum analogues in human ovarian-carcinoma cell lines.
Perez RP; Perez KM; Handel LM; Hamilton TC
Cancer Chemother Pharmacol; 1992; 29(6):430-4. PubMed ID: 1568285
[TBL] [Abstract][Full Text] [Related]
14. Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology.
Formenti SC; Shrivastava PN; Sapozink M; Jozsef G; Chan KK; Jeffers S; Morrow PC; Muggia FM
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):993-1001. PubMed ID: 8751408
[TBL] [Abstract][Full Text] [Related]
15. Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery.
Kelland LR; Jones M; Abel G; Valenti M; Gwynne J; Harrap KR
Cancer Chemother Pharmacol; 1992; 30(1):43-50. PubMed ID: 1586979
[TBL] [Abstract][Full Text] [Related]
16. Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia.
Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Alvarez Sotomayor E
Cancer Chemother Pharmacol; 1990; 26(2):127-34. PubMed ID: 2347038
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line.
Kimura E; Howell SB
Cancer Chemother Pharmacol; 1993; 32(6):419-24. PubMed ID: 7903066
[TBL] [Abstract][Full Text] [Related]
18. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
19. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
20. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
Chen G; Zeller WJ; Todorov DK
Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
